Clinical Trial Detail

NCT ID NCT02277457
Title Personalized Adaptive Radiation Therapy With Individualized Systemic Targeted Therapy (PARTIST) for Locally Advanced, Non-small Cell Lung Cancer With Genomic Driver Mutations
Recruitment Withdrawn
Gender both
Phase Phase I
Variant Requirements yes
Sponsors University of Michigan Cancer Center
Indications

lung non-small cell carcinoma

Therapies

Crizotinib

Erlotinib

Age Groups: adult

Additional content available in CKB BOOST